Background And Aims Of The Study: Impact wear grooves have been observed in the occluder discs of clinically explanted Björk-Shiley Delrin (BSD) heart valves due to repetitive closing impacts against the inlet strut. We examined whether this impact wear could increase the disc-to-strut gap, which could in turn affect the retention of occluder disc.
Materials And Methods: Three BSD heart valves with deep wear grooves were tested in a left ventricular assist device set-up simulating dynamic conditions that would facilitate the dislodgement.
Results: The disc was found to be rotating within the flange during the testing and no embolization of the occluder disc occurred in any of the BSD valves tested. The Björk retention limit and the physical retention limit were calculated for each valve. The Björk retention limit is defined as (disc well depth)-(disc-to strut gap)-(1/2 outlet strut wire diameter) and the physical retention as (disc well depth)-(disc-to strut gap).
Conclusion: The disc retention would not be affected by the impact wear grooves as long as the disc-to-strut gap did not exceed the physical retention limit.
Download full-text PDF |
Source |
---|
Front Nutr
January 2025
Department of BioSciences, School of Bio Science and Technology (SBST), Vellore Institute of Technology, Vellore, India.
Consumption of plant-based food is steadily increasing and follows an augmented trend owing to their nutritive, functional, and energy potential. Different bioactive fractions, such as phenols, flavanols, and so on, contribute highly to the nutritive profile of food and are known to have a sensitivity toward higher temperatures. This limits the applicability of traditional thermal treatments for plant products, paving the way for the advancement of innovative and non-thermal techniques such as pulsed electric field, microwave, ultrasound, cold plasma, and high-pressure processing.
View Article and Find Full Text PDFNature
January 2025
German Centre for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany.
Cardiomyocytes can be implanted to remuscularize the failing heart. Challenges include sufficient cardiomyocyte retention for a sustainable therapeutic impact without intolerable side effects, such as arrhythmia and tumour growth. We investigated the hypothesis that epicardial engineered heart muscle (EHM) allografts from induced pluripotent stem cell-derived cardiomyocytes and stromal cells structurally and functionally remuscularize the chronically failing heart without limiting side effects in rhesus macaques.
View Article and Find Full Text PDFInt J Biol Macromol
January 2025
College of Food Science and Engineering, Yangzhou University, Yang Zhou 225127, China. Electronic address:
Quercetin (Que) is a polyhydroxy flavonoid with strong inhibitory activity against cancer cells. However, the poor water solubility and low bioavailability of Que. limit its application in the functional food industry.
View Article and Find Full Text PDFJ Control Release
January 2025
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun 130022, China. Electronic address:
Bone defects caused by osteoporosis, infection, diabetes, post-tumor resection, and nonunion often cause severe pain and markedly increase morbidity and mortality, which remains a significant challenge for orthopedic surgeons. The precise local treatments to these pathological complications is essential to avoid poor or failed bone repair. Hydrogel formulations serve as injectable innovative platforms that overcome microenvironmental obstacles and as delivery systems for controlled release of various bioactive substances to bone defects in a targeted manner.
View Article and Find Full Text PDFNeuro Oncol
January 2025
Department of Medicine, Division of Experimental Medicine, McGill University.
Background: Glioblastoma is an aggressive brain cancer with a 5-year survival rate of 5-10%. Current therapeutic options are limited, due in part to drug exclusion by the blood-brain barrier, restricting access of targeted drugs to the tumor. The receptor for the type 1 insulin-like growth factor (IGF-1R) was identified as a therapeutic target in glioblastoma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!